MedPath

The Effect of Laparoscopic Splenectomy and Azygoportal Disconnection on Liver Reserve Function for Cirrhosis Patients

Not Applicable
Recruiting
Conditions
Portal Hypertension
Cirrhosis, Liver
Splenectomy; Status
Interventions
Procedure: Laparoscopic splenectomy and azygoportal disconnection
Registration Number
NCT05325437
Lead Sponsor
Northern Jiangsu People's Hospital
Brief Summary

In this study, the investigators compared the improvement of liver reserve function related indicators in patients with liver cirrhosis after laparoscopic splenectomy and azygoportal disconnection. To determine whether surgical treatment can help enhance postoperative liver reserve function and improve patient prognosis.

Detailed Description

The patients were enrolled according to the research criteria, and collected the general basic information of the patients. After the preoperative preparation was perfected, the same surgical team performed laparoscopic splenectomy and azygoportal disconnection, and the same nursing team performed the nursing after the operation. Then, patients received a unified treatment plan after surgery, including medication, other treatments and follow-up. During the treatment, the liver reserve function related indicators of the patients were monitored before surgery, 3, 6, 12 and 24 months after surgery, including TBIL, DBIL, ALB, ALT, INR, PT, Child-Pugh, ascites, prealbumin, ICG-K, ICG-R 15 and ICG-T/2.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
20
Inclusion Criteria
  • A clinical, radiological or histologic diagnosis of cirrhosis of any etiology
  • Splenomegaly with secondary hypersplenism
  • gastroesophageal variceal bleeding
  • Informed consent to participate in the study
Exclusion Criteria
  • Hepatocellular carcinoma or any other malignancy,
  • Child-Pugh grade C
  • Recent peptic ulcer disease
  • History of Hemorrhagic stroke
  • Pregnancy.
  • Uncontrolled Hypertension
  • Human immunodeficiency virus (HIV) infection

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Experimental GroupLaparoscopic splenectomy and azygoportal disconnectionLaparoscopic splenectomy and azygoportal disconnection
Primary Outcome Measures
NameTimeMethod
Liver reserve function ICG-K at 3 months after surgery.3 months

The level of liver reserve function ICG-K at 3 months after surgery.

Liver reserve function ICG-T/2 at 6 months after surgery.6 months

The level of liver reserve function ICG-T/2 at 6 months after surgery.

Liver reserve function ICG-K at 6 months after surgery.6 months

The level of liver reserve function ICG-K at 6 months after surgery.

Liver reserve function ICG-K at 24 months after surgery.24 months

The level of liver reserve function ICG-K at 24 months after surgery.

Liver reserve function ICG-R 15 at 3 months after surgery.3 months

The level of liver reserve function ICG-R 15 at 3 months after surgery.

Liver reserve function ICG-T/2 at 24 months after surgery.24 months

The level of liver reserve function ICG-T/2 at 24 months after surgery.

Liver reserve function ICG-R 15 at 6 months after surgery.6 months

The level of liver reserve function ICG-R 15 at 6 months after surgery.

Liver reserve function ICG-T/2 at 3 months after surgery.3 months

The level of liver reserve function ICG-T/2 at 3 months after surgery.

Liver reserve function ICG-K at 12 months after surgery.12 months

The level of liver reserve function ICG-K at 12 months after surgery.

Liver reserve function ICG-R 15 at 12 months after surgery.12 months

The level of liver reserve function ICG-R 15 at 12 months after surgery.

Liver reserve function ICG-R 15 at 24 months after surgery.24 months

The level of liver reserve function ICG-R 15 at 24 months after surgery.

Liver reserve function ICG-T/2 at 12 months after surgery.12 months

The level of liver reserve function ICG-T/2 at 12 months after surgery.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Clinical Medical College of Yangzhou University

🇨🇳

Yangzhou, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath